Navigation Links
Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
Date:8/30/2011

REDWOOD CITY, Calif., Aug. 30, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive results from a randomized, double-blind, Phase 2b, dose-ranging study of its formoterol fumarate metered dose inhaler (FF MDI; PT005), a long-acting beta-2 agonist (LABA) compared to placebo and Foradil® Aerolizer® in patients with moderate-to-severe COPD. All doses of FF MDI tested produced highly statistically significant improvements in lung function (FEV1 AUC 0-12) compared to placebo (p<0.0001). Dose ordering (incremental increase in efficacy with increasing doses) was observed across the three FF MDI doses evaluated, and the two lower doses tested were comparable to 12 mcg Foradil, the currently approved dose. This study marks the fourth in a series of detailed clinical evaluations of FF by Pearl in its novel MDI formulation platform, and significantly expands the safety and efficacy database of FF MDI. Detailed results of this study will be presented at a future conference.

"Successful completion of this study is an important milestone in the development of PT003, Pearl's combination of FF with glycopyrrolate, a long acting muscarinic antagonist (LAMA). The dose ordering and consistent response observed in this study confirm the robustness of Pearl's breakthrough formulation platform, and strengthen the value of FF MDI as the LABA arm of the PT003 program," commented Colin Reisner, Pearl's chief medical officer and executive vice president of clinical development. "The totality of data from this and previous studies provides Pearl with the confidence to select a dose of FF MDI to progress into PT003 Phase 3 studies."

Chuck Bramlage, Pearl's chief executive officer added, "This study was completed in only three months, demonstrating the drive of the Pearl development
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
2. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
3. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
4. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
5. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
6. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
7. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
8. Precision Therapeutics Named on Inc. 500
9. 5000 2011 List and Recognized for Achievements in Personalized Medicine Industry
10. Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval
11. Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... a Little Help ... Series,PSA Expands Partnership Between VH1 and Nothing But Nets to Prevent Malaria ... in Africa, ... very serious issue in a new Public,Service Announcement (PSA) created by VH1 for Nothing But ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today announced ... consortium led by the University of North Carolina ... Bill & Melinda Gates Foundation,(the "Gates Foundation"), to ... leishmania. This grant is part of the $22.6,million ...
Cached Medicine Technology:'Best Week Ever' for Nothing But Nets 2'Best Week Ever' for Nothing But Nets 3Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:4/20/2014)... of cell in the lining of the bladder is ... to researchers at the Stanford University School of Medicine. ... to pinpoint the normal cell type that can give ... to show that most bladder cancers and their associated ... why many human bladder cancers recur after therapy. , ...
(Date:4/18/2014)... medical-testing device is being prepped to enter the ... diagnosis of certain diseases in remote areas, thanks ... of investigations aboard the International Space Station on ... space-tested concept of capillary flow to diagnose infectious ... Kelso, Ph.D., a researcher at Northwestern University in ...
(Date:4/18/2014)... neuroscientists have made a discovery that turns 160 years ... insulating material long known to be essential for the ... cells, is not as ubiquitous as thought, according to ... the Harvard Stem Cell Institute (HSCI) and the University,s ... with Professor Jeff Lichtman, of Harvard,s Department of Molecular ...
(Date:4/18/2014)... did it make you feel? According to psychologists, remembering ... as how sad you were or how embarrassed you ... can,t stop thinking about it. , When these ... the memories, rather than how you felt, is a ... effects of these memories, a new study suggests. , ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
Breaking Medicine News(10 mins):Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2
... study raises the question, do barriers to health ... risk of tuberculosis? The study, published in the ... Diseases and now available online, suggests that ... seeking care than documented immigrants or U.S.-born patients, ...
... CHICAGO October 29, 2008 Shire plc (LSE: ... announced results from a 13-hour analog classroom study in ... Deficit Hyperactivity Disorder (ADHD). In this study, researchers ... time point measured (1.5 hours) through the last time ...
... 29 Trust for America,s,Health (TFAH) released ... Why Emerging,Infectious Diseases Are a Threat to ... die annually from newly emerging and re-emerging,infectious ... during a,severe flu pandemic or yet-unknown disease ...
... ARE PASSIVE AND INEFFECTIVE, NEW YORK, Oct. ... should be using the most effective tool,to protect ... Betsy,McCaughey, Ph.D., Chairman of the not-for-profit Committee to ... physicians., Today, RID is releasing a new ...
... drug resistance and climate change as culprits , , WEDNESDAY, ... die each year from infectious diseases, and that number ... That dire news was delivered in a report, ... Threat to America , released Wednesday by the Trust ...
... Foundation,Radiology Group (FRG) signed a multi-year contract with ... of diagnostic,imaging services effective December 31, 2008., ... Pennsylvania,and services multiple counties in north central Pennsylvania ... wide range of primary and,secondary health care services ...
Cached Medicine News:Health News:Health-care barriers for undocumented immigrants: Raising tuberculosis risk? 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 3Health News:New Report Finds Rising Risk of Infectious Diseases in America 2Health News:New Report Finds Rising Risk of Infectious Diseases in America 3Health News:New Report Finds Rising Risk of Infectious Diseases in America 4Health News:New Report Finds Rising Risk of Infectious Diseases in America 5Health News:New Report Finds Rising Risk of Infectious Diseases in America 6Health News:Professional Sports Teams Should Use MRSA Screening and Other Aggressive Methods to Prevent Staph Infections 2Health News:Threat From Infectious Diseases Growing 2Health News:Threat From Infectious Diseases Growing 3Health News:Foundation Radiology Group Announces Multi-Year Deal with Charles Cole Memorial Hospital 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: